Clear market notes built around the JSE, the rand, and what matters locally.

2026-09-28 15:15 • The Motley Fool Mixed Axe Cap view: Selective

EQT Corporation is recommended as a superior natural gas investment compared to LNG exporters. Unlike LNG terminal operators who lock in long-term contracts, EQT has greater upside potential through its integrated gas production model, ownership of midstream infrastructure including the Mountain Valley Pipeline, and exposure to both LNG markets and AI-driven power demand. The company offers better free cash flow durability at lower gas prices while capitalizing on premium market access.

Axe note: EQT’s integrated natural gas model offers more upside than LNG exporters, a useful angle for rand-linked investors watching USD/ZAR.

2026-09-28 14:28 • The Motley Fool Mixed Axe Cap view: Selective

Moderna's stock has surged over 550% in 2026 following positive Phase 3 trial results for intismeran, a personalized cancer vaccine developed with Merck for melanoma treatment. Despite the excitement and analyst upgrades, the author argues the stock is overvalued at current levels (~$200), with consensus price targets around $77, and cautions against buying at these valuations.

Axe note: Moderna’s stock price surged 550% in 2026 on promising cancer vaccine data but looks dangerously overpriced at current levels.

2026-09-28 14:27 • The Motley Fool Positive Axe Cap view: Selective

With inflation rising to 3.4% in August and potentially climbing further, two actively managed ETFs are positioned to outperform during inflationary periods: the Avantis Inflation Focused ETF (AVIE), which invests in inflation-correlated sectors like energy and healthcare, and the VanEck Real Assets ETF (RAAX), which focuses on commodities and real assets. Both have demonstrated strong performance when inflation spikes, though they underperform during bull markets.

Axe note: Inflation is climbing, and these ETFs have historically shielded portfolios when prices rise.